Dr. Stefania Cheli has a three-year degree in Medical Biotechnology from the University of Milan, Italy, and Master's degree in Biotechnology Applied to Medical Sciences from the University of Turin, Italy. Her PhD in Biotechnology Applied to Medical Sciences was conferred by the University of Milan. Since 2022, she has been employed as a Professional Technical Collaborator at the clinical research center within the ICPS, Pharmacovigilance & Clinical Research, Department of Biomedical and Clinical Sciences, University Hospital Luigi Sacco, ASST Fatebenefratelli Sacco, Università degli Studi di Milano, Italy. In this role, she is responsible for the coordination and management of interventional and observational studies conducted in accordance with Good Clinical Practice (GCP) guidelines. Previously, from 2011 to 2022, Dr. Stefania Cheli was a Professional Technical Collaborator, biotoxicologist technician, at the Departmental Simple Unit of Clinical Pharmacology, ASST Fatebenefratelli Sacco, Milan, where her primary focus was on the execution of pharmacogenetic analyses. Her professional experience includes coordinating clinical studies, conducting pharmacogenetic analyses, laboratory management, and student tutoring. Her areas of expertise are molecular biology, medical genetics, population genetics, and cell biology. Dr. Cheli is the author of 46 scientific articles published in peer-reviewed journals (H-index: 13; citations: 708).